A. Villanueva
Hepatology · 2008–2019
A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 101 citations into it; #62 of 151 by trust here, #34 by citations
Whom A. Villanueva trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Villanueva overall
Papers from A. Villanueva's perspective
Ordered by how strongly the researchers A. Villanueva trusts endorse each paper. Same corpus, a different order for every researcher.
- Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling (Hepatology)
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells (Nature Medicine)
- Molecular pathogenesis of human hepatocellular carcinoma (Nature Genetics)
- Summaries of Affymetrix GeneChip probe level data. (Nucleic Acids Research)
- Characterizing the cancer genome in lung adenocarcinoma (Nature)
- Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
- Hepatocellular carcinoma pathogenesis: from genes to environment (Nature Reviews. Cancer)
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets (Hepatology)
- Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. (Journal of Clinical Oncology)
- Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Their papers
- Pivotal role of mTOR signaling in hepatocellular carcinoma. (2008) — 725 citations
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (2008) — 1,244 citations
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling (2008) — 1,383 citations
- Focal Gains of Vascular Endothelial Growth Factor A and Molecular Classification of Hepatocellular Carcinoma (2008) — 647 citations
- β-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma (2019) — 600 citations
- Tumour evolution in hepatocellular carcinoma (2019) — 699 citations
- Hepatocellular Carcinoma. (2019) — 1,607 citations
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features (2017) — 804 citations
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis (2016) — 1,028 citations
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets (2015) — 1,627 citations
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. (2015) — 1,184 citations
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma (2009) — 1,102 citations